What Retina Consultants of America does

Retina Consultants of America is a physician-led management services organization that operates a national network of 30+ retina practices with nearly 300 fellowship-trained retina specialists across 23+ U.S. states. Founded in 2019 and headquartered in Southlake, Texas, RCA provides business-level support — including administration, IT, payor contracting, compliance, and marketing — to affiliated practices whose physicians retain independent clinical decision-making authority. The network includes major regional platforms such as Retina Consultants of Texas (24 Houston/San Antonio locations, 100,000+ annual patients, 190+ active clinical trials), Vitreoretinal Consultants of NY (19 physicians), Illinois Retina Associates (13 Chicago-area locations), Retinal Consultants Medical Group (13 Northern California locations), and Tennessee Retina, among others.

The company's core technology platform centers on advanced retinal diagnostics — particularly high-density OCT imaging — delivered at scale across the network. RCA Research, the organization's clinical trials division, runs a substantial portfolio of active studies, giving the network preferred-partner status with biopharma sponsors and early access to investigational therapies for age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and geographic atrophy. The company is investing in oculomics research, using AI to analyze retinal imaging for biomarkers of systemic disease (Alzheimer's, cardiovascular, and metabolic conditions).

RCA's business model is an MSO/physician services model: revenue is generated through insurance-reimbursed clinical encounters — anti-VEGF injections, laser treatments, and vitreoretinal surgery — with physicians maintaining clinical autonomy while the corporate entity captures scale economics on the business side. RCA was acquired by Cencora Inc. (formerly AmerisourceBergen) for approximately $4.6 billion in January 2025, and is expanding further via the announced $1.1 billion acquisition of EyeSouth Partners' retina business.

Name

Retina Consultants of America

Legal name

Retina Consultants of America

Website

https://retinaconsultantsofamerica.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

51–100 employees

Short description

Retina Consultants of America is a physician-led MSO operating a national network of 30+ retina practices with nearly 300 specialists across 23+ states. Acquired by Cencora for $4.6 billion in January 2025, RCA provides business support while affiliated physicians retain clinical autonomy.

Ownership category

akta.pro rank

Product category

Specialty Retinal Healthcare Services

NAICS

Offices of Optometrists (62132), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Facilities Support Management Services (8744)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industries

Managed Vision Care Networks (Provider Network Management) (HLAEAJAJ), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

Keywords

• Retinal care services
• Physician practice management
• Clinical research trials
• Vitreoretinal medical care
• Ophthalmology specialty network

Headquarters

HQ city

Southlake

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Healthcare Services: RCA operates as a Management Services Organization providing business support to affiliated retina practices. Revenue is generated through healthcare service delivery including diagnostic procedures, medical treatments, and surgical interventions for retinal conditions. The MSO model provides administrative, operational, and strategic support while physicians deliver clinical care.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Retina Consultants of America operates a nationwide network of fellowship-trained retina specialists delivered through 30+ affiliated partner practices. The organization functions as a physician-led Management Services Organization (MSO) that provides business, operational, technology, and clinical research support to independent retina practices while physicians retain clinical decision-making authority. Core services include diagnostic imaging (OCT), anti-VEGF injections, laser treatments, and vitreoretinal surgery for conditions such as macular degeneration, diabetic retinopathy, retinal detachment, and geographic atrophy, with revenue generated through insurance-reimbursed medical services.

Product overview

Retina Consultants of America is a physician-led network of elite retina practices operating as a unified platform. The core offering is the RCA Network, which comprises 30+ partner practices across 23+ states (including Retina Consultants of Texas, Vitreoretinal Consultants of NY, Retinal Consultants Medical Group, and others), all supported by business-level resources while maintaining clinical autonomy. The network also includes RCA Research (rcaresearch.com), which conducts clinical trials for new treatments. The platform provides patients access to retina specialists through a Find a Doctor locator tool. The company was acquired by Cencora (formerly AmerisourceBergen) for $4.6 billion in January 2025 and is expanding through pending acquisition of EyeSouth Partners' retina business for $1.1 billion.

Differentiator

Problem solved

Functional benefit

Brands

• RCA Research: Clinical research division of Retina Consultants of America focused on groundbreaking clinical trials and advancing retinal care treatments
• RCA

Products and services

• Retina Consultants of America Network A nationwide network of 30+ elite retina practices supported by centralized business services. Provides adult patients access to fellowship-trained retina specialists for diagnosis, medical treatment, surgical intervention, and clinical trial enrollment across 20+ U.S. states.
• RCA Research Clinical Trials Program Network-wide clinical trial infrastructure enabling participation in major retinal clinical trials. Retina Consultants of Texas alone operates 190+ active clinical trials. Provides eligible patients access to investigational retinal therapies before commercial availability.
• MSO Practice Partnership Services Centralized business, administrative, technology, marketing, compliance, and strategic support provided to independent retina practices that join the RCA network. Physicians retain clinical autonomy and decision-making authority while benefiting from MSO-level operational infrastructure.
• Find a Doctor Locator Patient-facing online search tool that allows prospective patients to locate RCA network retina specialists by location across 20+ U.S. states.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• EyeSouth PartnerscoreStrategic or Co-development Partner · 23 March 2026Cencora announced a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, with affiliated retina physicians joining Retina Consultants of America. The transaction is expected to enhance access to innovative retina treatments and expand clinical trial involvement. Pending regulatory approval, this acquisition will add EyeSouth's affiliated physicians to the RCA network, expanding the organization's footprint and physician count.
• Cencora, Inc.flagshipStrategic or Co-development Partner · 7 January 2025Cencora (formerly AmerisourceBergen), a Fortune 25 pharmaceutical solutions organization with over $300 billion in annual revenue, acquired Retina Consultants of America for $4.6 billion in January 2025. The acquisition expands Cencora's specialty healthcare services and positions RCA within a larger healthcare platform. RCA maintains operations as a physician-led MSO while benefiting from Cencora's capital resources and healthcare ecosystem connections.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/RetinaConsultantsOfAmerica
• LinkedInlinkedin.com/company/retina-consultants-of-america

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries23 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Consultants of America